{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:23:30Z","timestamp":1791887010797,"version":"4.3.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82072693, 81902417, 82172884, U21A20374, 82472954"],"award-info":[{"award-number":["82072693, 81902417, 82172884, U21A20374, 82472954"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shanghai","award":["18ZR1404500, 23ZR1412100"],"award-info":[{"award-number":["18ZR1404500, 23ZR1412100"]}]},{"name":"Young Scientist Project of National Key Research and Development Program of China","award":["2022YFC2804800"],"award-info":[{"award-number":["2022YFC2804800"]}]},{"name":"The Scientific Innovation Project of Shanghai Education Committee","award":["2019-01-07-00-07-E00057"],"award-info":[{"award-number":["2019-01-07-00-07-E00057"]}]},{"name":"Shanghai Municipal Science and Technology Major Project","award":["21JC1401500"],"award-info":[{"award-number":["21JC1401500"]}]},{"name":"Clinical and Scientific Innovation Project of Shanghai Hospital Development Center","award":["SHDC12018109"],"award-info":[{"award-number":["SHDC12018109"]}]},{"name":"Clinical Research Plan of Shanghai Hospital Development Center","award":["SHDC2020CR1006A"],"award-info":[{"award-number":["SHDC2020CR1006A"]}]},{"name":"National Key Research and Development Program of China","award":["2020YFA0803202, 2022YFC280480"],"award-info":[{"award-number":["2020YFA0803202, 2022YFC280480"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04205-x","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:54:40Z","timestamp":1761195280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of tertiary lymphoid structures via 18F-FDG PET\/CT scan in patients with pancreatic adenocarcinoma"],"prefix":"10.1007","volume":"74","author":[{"given":"Yu","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"issue":"3","key":"4205_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4205_CR2","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M (2023) Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention [J]. Gastroenterology 164(5):752\u2013765","journal-title":"Gastroenterology"},{"issue":"7","key":"4205_CR3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","volume":"18","author":"AP Klein","year":"2021","unstructured":"Klein AP (2021) Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors [J]. Nat Rev Gastroenterol Hepatol 18(7):493\u2013502","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4205_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41571-018-0112-1","volume":"16","author":"O Strobel","year":"2019","unstructured":"Strobel O, Neoptolemos J, J\u00e4ger D et al (2019) Optimizing the outcomes of pancreatic cancer surgery [J]. Nat Rev Clin Oncol 16(1):11\u201326","journal-title":"Nat Rev Clin Oncol"},{"key":"4205_CR5","volume":"383","author":"M del Chiaro","year":"2023","unstructured":"del Chiaro M, Sugawara T, Karam SD et al (2023) Advances in the management of pancreatic cancer [J]. BMJ 383:e073995","journal-title":"BMJ"},{"issue":"21","key":"4205_CR6","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1158\/1078-0432.CCR-21-3452","volume":"28","author":"B Bockorny","year":"2022","unstructured":"Bockorny B, Grossman JE, Hidalgo M (2022) Facts and hopes in immunotherapy of pancreatic cancer. Clin Cancer Res 28(21):4606\u20134617","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4205_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu ZI, O\u2019Reilly EM (2024) Therapeutic developments in pancreatic cancer [J]. Nat Rev Gastroenterol Hepatol 21(1):7\u201324","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"4205_CR8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear AS, Vonderheide RH, O\u2019Hara MH (2020) Challenges and opportunities for pancreatic cancer immunotherapy [J]. Cancer Cell 38(6):788\u2013802","journal-title":"Cancer Cell"},{"issue":"8","key":"4205_CR9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein AN, Brekken RA, Maitra A (2020) Pancreatic cancer stroma: an update on therapeutic targeting strategies [J]. Nat Rev Gastroenterol Hepatol 17(8):487\u2013505","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7791","key":"4205_CR10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink BA, Reddy SM, Gao J et al (2020) B cells and tertiary lymphoid structures promote immunotherapy response [J]. Nature 577(7791):549\u2013555","journal-title":"Nature"},{"issue":"6","key":"4205_CR11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J et al (2019) Tertiary lymphoid structures in the era of cancer immunotherapy [J]. Nat Rev Cancer 19(6):307\u2013325","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4205_CR12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","volume":"74","author":"J Goc","year":"2014","unstructured":"Goc J, Germain C, Vo-Bourgais TK et al (2014) Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells. Cancer Res 74(3):705\u2013715","journal-title":"Cancer Res"},{"issue":"7","key":"4205_CR13","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI67428","volume":"123","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien C, Loi S, Garaud S et al (2013) CD4\u207a follicular helper T cell infiltration predicts breast cancer survival [J]. J Clin Invest 123(7):2873\u20132892","journal-title":"J Clin Invest"},{"key":"4205_CR14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1479-5876-11-54","volume":"11","author":"PA Ascierto","year":"2013","unstructured":"Ascierto PA, Capone M, Urba WJ et al (2013) The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment [J]. J Transl Med 11:54","journal-title":"J Transl Med"},{"issue":"5795","key":"4205_CR15","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","volume":"313","author":"J Galon","year":"2006","unstructured":"Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome [J]. Science 313(5795):1960\u20131964","journal-title":"Science"},{"issue":"7791","key":"4205_CR16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","volume":"577","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, Lauss M, Sanna A et al (2020) Tertiary lymphoid structures improve immunotherapy and survival in melanoma [J]. Nature 577(7791):561\u2013565","journal-title":"Nature"},{"key":"4205_CR17","doi-asserted-by":"crossref","first-page":"1049043","DOI":"10.3389\/fimmu.2022.1049043","volume":"13","author":"Y Gao","year":"2022","unstructured":"Gao Y, Wu C, Chen X et al (2022) PET\/CT molecular imaging in the era of immune-checkpoint inhibitors therapy [J]. Front Immunol 13:1049043","journal-title":"Front Immunol"},{"issue":"2","key":"4205_CR18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1148\/radiol.212481","volume":"304","author":"DJ Hughes","year":"2022","unstructured":"Hughes DJ, Subesinghe M, Taylor B et al (2022) (18)F FDG PET\/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer [J]. Radiology 304(2):246\u2013264","journal-title":"Radiology"},{"issue":"8","key":"4205_CR19","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00262-020-02560-5","volume":"69","author":"KG Mitchell","year":"2020","unstructured":"Mitchell KG, Amini B, Wang Y et al (2020) (18)F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer [J]. Cancer Immunol Immunother 69(8):1519\u20131534","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"4205_CR20","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00259-019-04500-7","volume":"47","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhao N, Wu Z et al (2020) New insight on the correlation of metabolic status on (18)F-FDG PET\/CT with immune marker expression in patients with non-small cell lung cancer [J]. Eur J Nucl Med Mol Imaging 47(5):1127\u20131136","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4205_CR21","volume":"2020","author":"L Zhao","year":"2020","unstructured":"Zhao L, Liu J, Shi J et al (2020) Relationship between SP142 PD-L1 expression and (18)F-FDG uptake in Non-Small-Cell Lung Cancer. Contrast Media Mol Imaging 2020:2010924","journal-title":"Contrast Media Mol Imaging"},{"issue":"1119","key":"4205_CR22","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200397","volume":"94","author":"L Zhao","year":"2021","unstructured":"Zhao L, Liu J, Wang H et al (2021) Association between (18)F-FDG metabolic activity and programmed death ligand-1 (PD-L1) expression using 22C3 immunohistochemistry assays in non-small cell lung cancer (NSCLC) resection specimens [J]. Br J Radiol 94(1119):20200397","journal-title":"Br J Radiol"},{"issue":"2","key":"4205_CR23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-020-05619-0","volume":"181","author":"T Hirakata","year":"2020","unstructured":"Hirakata T, Fujii T, Kurozumi S et al (2020) FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer [J]. Breast Cancer Res Treat 181(2):331\u2013338","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"4205_CR24","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s00259-018-4208-8","volume":"46","author":"R Chen","year":"2019","unstructured":"Chen R, Zhou X, Liu J et al (2019) Relationship between the expression of PD-1\/PD-L1 and (18)F-FDG uptake in bladder cancer [j]. Eur J Nucl Med Mol Imaging 46(4):848\u2013854","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"4205_CR25","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.7150\/jca.38689","volume":"11","author":"H Jiang","year":"2020","unstructured":"Jiang H, Zhang R, Jiang H et al (2020) Retrospective analysis of the prognostic value of PD-L1 expression and (18)F-FDG PET\/CT metabolic parameters in colorectal cancer [J]. J Cancer 11(10):2864\u20132873","journal-title":"J Cancer"},{"issue":"4","key":"4205_CR26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5230\/jgc.2017.17.e43","volume":"17","author":"S Lee","year":"2017","unstructured":"Lee S, Choi S, Kim SY et al (2017) Potential utility of FDG PET-CT as a non-invasive tool for monitoring local immune responses [J]. J Gastric Cancer 17(4):384\u2013393","journal-title":"J Gastric Cancer"},{"issue":"1","key":"4205_CR27","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1038\/s41598-021-91404-y","volume":"11","author":"S Park","year":"2021","unstructured":"Park S, Min EK, Bae SJ et al (2021) Relationship of the standard uptake value of (18)F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring \u2265 1 cm [J]. Sci Rep 11(1):12046","journal-title":"Sci Rep"},{"issue":"3","key":"4205_CR28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10549-019-05339-0","volume":"177","author":"S Sasada","year":"2019","unstructured":"Sasada S, Shiroma N, Goda N et al (2019) The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer [J]. Breast Cancer Res Treat 177(3):651\u2013657","journal-title":"Breast Cancer Res Treat"},{"key":"4205_CR29","doi-asserted-by":"crossref","unstructured":"KIST DE RUIJTER L, VAN DE DONK P P, HOOIVELD-NOEKEN J S, et al. 2022 Whole-body CD8(+) T cell visualization before and during cancer immunotherapy: a phase 1\/2 trial [J]. Nat Med. 28(12): 2601\u20132610.","DOI":"10.1038\/s41591-022-02084-8"},{"key":"4205_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002118","author":"W Mu","year":"2021","unstructured":"Mu W, Jiang L, Shi Y et al (2021) Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET\/CT images. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-002118","journal-title":"J Immunother Cancer"},{"issue":"4","key":"4205_CR31","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1097\/RLU.0000000000002453","volume":"44","author":"T Nobashi","year":"2019","unstructured":"Nobashi T, Baratto L, Reddy SA et al (2019) Predicting response to immunotherapy by evaluating tumors, lymphoid cell-rich organs, and immune-related adverse events using FDG-PET\/CT [j]. Clin Nucl Med 44(4):e272\u2013e279","journal-title":"Clin Nucl Med"},{"issue":"6","key":"4205_CR32","volume":"43","author":"H \u00d6nner","year":"2024","unstructured":"\u00d6nner H, Calderon Tobar MN, Perkta\u015f L et al (2024) Evaluating the role of sarcopenia and [(18)F]FDG PET\/CT parameters in prognosis of pancreatic ductal adenocarcinoma. Rev Esp Med Nucl Imagen Mol (Engl Ed) 43(6):500046","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"issue":"19","key":"4205_CR33","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao L, Huang C, CUI ZHOU D et al (2021) Proteogenomic characterization of pancreatic ductal adenocarcinoma [J]. Cell 184(19):5031-5052.e5026","journal-title":"Cell"},{"issue":"2","key":"4205_CR34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ijc.32982","volume":"147","author":"R Tokunaga","year":"2020","unstructured":"Tokunaga R, Nakagawa S, Sakamoto Y et al (2020) 12-chemokine signature, a predictor of tumor recurrence in colorectal cancer. Int J Cancer 147(2):532\u2013541","journal-title":"Int J Cancer"},{"issue":"4","key":"4205_CR35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12032-021-01635-2","volume":"39","author":"X Li","year":"2022","unstructured":"Li X, Wan Z, Liu X et al (2022) A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy [J]. Med Oncol 39(4):43","journal-title":"Med Oncol"},{"key":"4205_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-0716-0301-7_7","volume":"2117","author":"CB Steen","year":"2020","unstructured":"Steen CB, Liu CL, Alizadeh AA et al (2020) Profiling cell type abundance and expression in bulk tissues with CIBERSORTx [J]. Methods Mol Biol 2117:135\u2013157","journal-title":"Methods Mol Biol"},{"issue":"5930","key":"4205_CR37","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324(5930):1029\u20131033","journal-title":"Science"},{"issue":"1","key":"4205_CR38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0256-4947.75771","volume":"31","author":"A Almuhaideb","year":"2011","unstructured":"Almuhaideb A, Papathanasiou N, Bomanji J (2011) 18F-FDG PET\/CT imaging in oncology. Ann Saudi Med 31(1):3\u201313","journal-title":"Ann Saudi Med"},{"issue":"1","key":"4205_CR39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00330-024-10961-8","volume":"35","author":"DY Lee","year":"2025","unstructured":"Lee DY, Kim YI, Ryu JS (2025) Diagnostic ability of [(18)F]FDG PET\/CT for distinguishing benign from malignant spleen lesions. Eur Radiol 35(1):479\u2013486","journal-title":"Eur Radiol"},{"issue":"3","key":"4205_CR40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00259-022-06020-3","volume":"50","author":"PY Ouyang","year":"2023","unstructured":"Ouyang PY, Liu ZQ, Lin QG et al (2023) Benefit of [(18)F] FDG PET\/CT in the diagnosis and salvage treatment of recurrent nasopharyngeal carcinoma [J]. Eur J Nucl Med Mol Imaging 50(3):881\u2013891","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"4205_CR41","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1007\/s00259-022-05872-z","volume":"49","author":"X Wang","year":"2022","unstructured":"Wang X, Yang W, Zhou Q et al (2022) The role of (18)F-FDG PET\/CT in predicting the pathological response to neoadjuvant PD-1 blockade in combination with chemotherapy for resectable esophageal squamous cell carcinoma [J]. Eur J Nucl Med Mol Imaging 49(12):4241\u20134251","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"4205_CR42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","volume":"19","author":"WH Fridman","year":"2022","unstructured":"Fridman WH, Meylan M, Petitprez F et al (2022) B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome [J]. Nat Rev Clin Oncol 19(7):441\u2013457","journal-title":"Nat Rev Clin Oncol"},{"issue":"6576","key":"4205_CR43","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher TN, Thommen DS (2022) Tertiary lymphoid structures in cancer. Science 375(6576):eabf9419","journal-title":"Science"},{"issue":"7","key":"4205_CR44","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1158\/2326-6066.CIR-14-0027","volume":"2","author":"ER Lutz","year":"2014","unstructured":"Lutz ER, Wu AA, Bigelow E et al (2014) Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation. Cancer Immunol Res 2(7):616\u2013631","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"4205_CR45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon J, Bruni D (2019) Approaches to treat immune hot, altered and cold tumours with combination immunotherapies [J]. Nat Rev Drug Discov 18(3):197\u2013218","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4205_CR46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B, Zhang B, Li B et al (2024) Cold and hot tumors: from molecular mechanisms to targeted therapy [J]. Signal Transduct Target Ther 9(1):274","journal-title":"Signal Transduct Target Ther"},{"issue":"762","key":"4205_CR47","volume":"16","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang F, Peng D et al (2024) Activation and antitumor immunity of CD8(+) T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid. Sci Transl Med 16(762):eadk7399","journal-title":"Sci Transl Med"},{"issue":"12","key":"4205_CR48","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41577-021-00541-y","volume":"21","author":"K Depeaux","year":"2021","unstructured":"Depeaux K, Delgoffe GM (2021) Metabolic barriers to cancer immunotherapy [J]. Nat Rev Immunol 21(12):785\u2013797","journal-title":"Nat Rev Immunol"},{"key":"4205_CR49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cytogfr.2022.11.001","volume":"68","author":"L Ye","year":"2022","unstructured":"Ye L, Jiang Y, Zhang M (2022) Crosstalk between glucose metabolism, lactate production and immune response modulation [J]. Cytokine Growth Factor Rev 68:81\u201392","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"4205_CR50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","volume":"20","author":"AN Macintyre","year":"2014","unstructured":"Macintyre AN, Gerriets VA, Nichols AG et al (2014) The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function [J]. Cell Metab 20(1):61\u201372","journal-title":"Cell Metab"},{"issue":"9","key":"4205_CR51","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu L, Jin Y, Zhao X et al (2023) Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1 [J]. Cell Metab 35(9):1580-1596.e1589","journal-title":"Cell Metab"},{"key":"4205_CR52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.canlet.2021.06.028","volume":"520","author":"P Jin","year":"2021","unstructured":"Jin P, Li J, Meng Y et al (2021) PET\/CT metabolic patterns in systemic immune activation: a new perspective on the assessment of immunotherapy response and efficacy [J]. Cancer Lett 520:91\u201399","journal-title":"Cancer Lett"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04205-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04205-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04205-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T17:20:23Z","timestamp":1763054423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04205-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4205"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04205-x","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"30 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethics Committee of Fudan University Shanghai Cancer Center (ID:050432\u20134-2108*).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"345"}}